USANA Health Sciences Inc (USNA) Annual Income Statement (USD)
USNA Quarterly Financials (USD)
Frequently Asked Questions About USANA Health Sciences Inc (USNA) Stock
USANA Health Sciences Inc's (USNA) last reported annual revenue was USD 854.50 Million.
USANA Health Sciences Inc's (USNA) annual revenue growth rate based on the revenue reported in the past 5 years is : -4.23%
USANA Health Sciences Inc's(USNA) is profitable as of its last reported annual financials.
The net profit margin for USANA Health Sciences Inc's(USNA) from its laster reported year is 4.92%
The return on equity (ROE) for USANA Health Sciences Inc's(USNA) from its last reported annual financials is : 7.76%
The return on assets (ROA) for USANA Health Sciences Inc's(USNA) from its last reported annual financials is : 6.00%
The return on invested capital (ROIC) for USANA Health Sciences Inc's(USNA) from its last reported annual financials is : 6.08%
The Debt to Equity ratio for USANA Health Sciences Inc's(USNA) from its last reported annual financials is : 0.00%
The dividend yield for USANA Health Sciences Inc's(USNA) from its laster reported year is 0.00%
USANA Health Sciences Inc's(USNA) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Underpriced on free cash flow basis
The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for USNA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
